© 2026 NervNow™. All rights reserved.
ByNN Desk
Navina Raises $55M Series C to Expand AI-Powered Clinical Intelligence
Healthcare AI startup Navina has closed a $55M Series C led by Goldman Sachs to scale its AI copilot across U.S. outpatient care, reaching $100M total raised.
Healthcare AI startup Navina has closed a $55M Series C led by Goldman Sachs to scale its AI copilot across U.S. outpatient care, reaching $100M total raised.
Healthcare AI startup Navina has successfully closed a $55 million Series C funding round, bringing its total capital raised to $100 million. The round was led by Growth Equity at Goldman Sachs Alternatives, with continued participation from existing investors ALIVE Israel HealthTech Fund, Grove Ventures, and Vertex Ventures Israel.
Notably, this latest milestone comes after the company had previously raised a $22 million Series B in November 2022 and a $15 million Series A in October 2021, marking a steady and verified trajectory of institutional confidence in the company’s growth.
Navina’s AI copilot brings clinical intelligence to clinicians and care teams, transforming care and value-based outcomes. The platform turns fragmented patient data into a concise patient profile with actionable insights at every clinical touchpoint.
Furthermore, Navina’s software aggregates structured and unstructured clinical data to create patient profiles that augment the amount of information clinicians can access at the point of care.
As a result, physicians can move from scattered records to clear, actionable summaries — ultimately reducing missed diagnoses and improving both outcomes and efficiency.
The company’s growth, moreover, is already reflected in its operational footprint. The platform serves over 10,000 healthcare professionals across 1,300 clinics and supports the care of more than three million patients.
Also Read : Is AI Healthcare Really Reaching Tier-2 India?
In addition to this reach, the company has secured partnerships with industry leaders including agilon health, InnovaCare Health, Millennium Physician Group, and Privia Health, and was recently recognized as Best in KLAS 2025 for Clinician Digital Workflow.
According to the official announcement, this significant investment will accelerate Navina’s expansion across the U.S. healthcare market, enhance its proprietary AI technology, and further drive improvements in patient outcomes by bringing proactive clinical intelligence to every outpatient interaction.
Consequently, the company is well-positioned to deepen its presence in the high-growth value-based care segment a market that is rapidly adopting AI-driven tools to manage patient complexity at scale.
This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI.
Ronen Lavi, Co-founder and CEO of Navina.
AI is rapidly transforming modern healthcare, and Navina stands at the forefront of that transformation, delivering real, measurable value to thousands of clinicians
Irit Kahan, Managing Director in Growth Equity at Goldman Sachs Alternatives.
The funding, therefore, arrives at a pivotal moment. AI adoption in healthcare is accelerating rapidly, with clinical workflow solutions drawing particular attention from growth-stage investors. Navina’s trajectory from a $7M seed round in 2020 to $100M in total funding by 2025, reflects a broader shift toward AI tools that directly reduce physician burnout and improve diagnostic accuracy.
Disclaimer: This article is based on information sourced from publicly available reports and have not been independently verified by NervNow.
MORE ON STARTUPS & FUNDING:
Oasis Security Raises $120 Million to Govern AI Agent Access
Surf AI Raises $57M Series A to Scale AI Security Platform
Agnes AI Raises Tens of Millions in Funding
One-Year-Old Wonderful Raises $150M in New Funding
DiligenceSquared Raises $5M to Let AI Do What McKinsey Charges $1M For
